{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:30:59Z","timestamp":1778567459627,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,4]]},"DOI":"10.7759\/cureus.76911","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T18:08:33Z","timestamp":1736014113000},"source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the Effectiveness of MRI Versus CT in Identifying Retroperitoneal Lymph Node Metastasis in Testicular Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Reem M","family":"Aldossari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muaiyad","family":"Alkindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Othman M","family":"Alshamrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad E","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaden M","family":"Alosaimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taghreed A","family":"Alsaleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joud M","family":"Babegi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A","family":"Altabsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed J","family":"Alhazmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman M","family":"Alfawaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Budur A","family":"Qasem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Alfaleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33999","article-title":"Global patterns in testicular cancer incidence and mortality in 2020","volume":"151","author":"Znaor A","year":"2022","unstructured":"Znaor A, Skakkebaek NE, Rajpert-De Meyts E, et al.. Global patterns in testicular cancer incidence and mortality in 2020. Int J Cancer. 2022, 151:692-8. 10.1002\/ijc.33999","journal-title":"Int J Cancer"},{"key":"ref2","unstructured":"Key statistics for testicular cancer. (2024). Accessed. August 3, 2024: https:\/\/www.cancer.org\/cancer\/types\/testicular-cancer\/about\/key-statistics.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2022.06.009","article-title":"Worldwide distribution, risk factors, and temporal trends of testicular cancer incidence and mortality: a global analysis","volume":"5","author":"Huang J","year":"2022","unstructured":"Huang J, Chan SC, Tin MS, et al.. Worldwide distribution, risk factors, and temporal trends of testicular cancer incidence and mortality: a global analysis. Eur Urol Oncol. 2022, 5:566-76. 10.1016\/j.euo.2022.06.009","journal-title":"Eur Urol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012390","article-title":"Recent global trends in testicular cancer incidence and mortality","volume":"97","author":"Park JS","year":"2018","unstructured":"Park JS, Kim J, Elghiaty A, Ham WS. Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore). 2018, 97:e12390. 10.1097\/MD.0000000000012390","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S393819","article-title":"Testicular cancer in Saudi Arabia between 2004 and 2017","volume":"15","author":"Alghamdi IG","year":"2023","unstructured":"Alghamdi IG. Testicular cancer in Saudi Arabia between 2004 and 2017. Res Rep Urol. 2023, 15:37-45. 10.2147\/RRU.S393819","journal-title":"Res Rep Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55090552","article-title":"A population-based analysis of incidence, mortality, and survival in testicular cancer patients in Lithuania","volume":"55","author":"Drevinskaite M","year":"2019","unstructured":"Drevinskaite M, Patasius A, Kincius M, Jievaltas M, Smailyte G. A population-based analysis of incidence, mortality, and survival in testicular cancer patients in Lithuania. Medicina (Kaunas). 2019, 55:10.3390\/medicina55090552","journal-title":"Medicina (Kaunas)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001603","article-title":"Trends in the global, regional, and national burden of testicular cancer from 1990 to 2019: an observational study with 30-year global data","volume":"110","author":"Zhou X","year":"2024","unstructured":"Zhou X, Zhang Z, Ruan C, et al.. Trends in the global, regional, and national burden of testicular cancer from 1990 to 2019: an observational study with 30-year global data. Int J Surg. 2024, 110:4633-47. 10.1097\/JS9.0000000000001603","journal-title":"Int J Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.10319","article-title":"Testicular cancer: what the radiologist needs to know","volume":"200","author":"Kreydin EI","year":"2013","unstructured":"Kreydin EI, Barrisford GW, Feldman AS, Preston MA. Testicular cancer: what the radiologist needs to know. AJR Am J Roentgenol. 2013, 200:1215-25. 10.2214\/AJR.12.10319","journal-title":"AJR Am J Roentgenol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)52904-3","article-title":"Distribution of nodal metastases in nonseminomatous testis cancer","volume":"128","author":"Donohue J","year":"1982","unstructured":"Donohue J, Zachary J, Maynard B. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol. 1982, 128:315-20. 10.1016\/s0022-5347(17)52904-3","journal-title":"J Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)37036-2","article-title":"Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors","volume":"148","author":"Wood DP Jr","year":"1992","unstructured":"Wood DP Jr, Herr HW, Heller G, et al.. Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol. 1992, 148:1812-5. 10.1016\/s0022-5347(17)37036-2","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197402)33:2<340::aid-cncr2820330207>3.0.co;2-y","article-title":"Distribution of retroperitoneal lymph node metastases in testicular germinal tumors","volume":"33","author":"Ray B","year":"1974","unstructured":"Ray B, Hajdu SI, Whitmore WF Jr. Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer. 1974, 33:340-8. 10.1002\/1097-0142(197402)33:2&lt;340::aid-cncr2820330207&gt;3.0.co;2-y","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40134-013-0036-6","article-title":"Radiologic assessment of lymph nodes in oncologic patients","volume":"2","author":"Mao Y","year":"2014","unstructured":"Mao Y, Hedgire S, Harisinghani M. Radiologic assessment of lymph nodes in oncologic patients. Curr Radiol Rep. 2014, 2:36. 10.1007\/s40134-013-0036-6","journal-title":"Curr Radiol Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.10.005","article-title":"Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography","volume":"181","author":"Tarin TV","year":"2009","unstructured":"Tarin TV, Sonn G, Shinghal R. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol. 2009, 181:627-32; discussion 632-3. 10.1016\/j.juro.2008.10.005","journal-title":"J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60815-0","article-title":"Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study","volume":"380","author":"Pearce MS","year":"2012","unstructured":"Pearce MS, Salotti JA, Little MP, et al.. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012, 380:499-505. 10.1016\/S0140-6736(12)60815-0","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2360","article-title":"Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians","volume":"346","author":"Mathews JD","year":"2013","unstructured":"Mathews JD, Forsythe AV, Brady Z, et al.. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ. 2013, 346:f2360. 10.1136\/bmj.f2360","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.440","article-title":"Projected cancer risks from computed tomographic scans performed in the United States in 2007","volume":"169","author":"Berrington de Gonz\u00e1lez A","year":"2009","unstructured":"Berrington de Gonz\u00e1lez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009, 169:2071-7. 10.1001\/archinternmed.2009.440","journal-title":"Arch Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.20895","article-title":"Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI","volume":"25","author":"Semelka RC","year":"2007","unstructured":"Semelka RC, Armao DM, Elias J Jr, Huda W. Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI. J Magn Reson Imaging. 2007, 25:900-9. 10.1002\/jmri.20895","journal-title":"J Magn Reson Imaging"},{"key":"ref18","unstructured":"EAU guidelines on testicular cancer. (2024). Accessed. August 8, 2024: https:\/\/uroweb.org\/guidelines\/testicular-cancer."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0058","article-title":"Testicular cancer, version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Gilligan T","year":"2019","unstructured":"Gilligan T, Lin DW, Aggarwal R, et al.. Testicular cancer, version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019, 17:1529-54. 10.6004\/jnccn.2019.0058","journal-title":"J Natl Compr Canc Netw"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up","volume":"29","author":"Honecker F","year":"2018","unstructured":"Honecker F, Aparicio J, Berney D, et al.. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol. 2018, 29:1658-86. 10.1093\/annonc\/mdy217","journal-title":"Ann Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097. 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani M","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016, 5:210. 10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"ref23","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2024). Accessed. March 23, 2024: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2758","article-title":"The role of imaging in the diagnosis, staging, and management of testicular cancer","volume":"191","author":"Sohaib SA","year":"2008","unstructured":"Sohaib SA, Koh DM, Husband JE. The role of imaging in the diagnosis, staging, and management of testicular cancer. AJR Am J Roentgenol. 2008, 191:387-95. 10.2214\/AJR.07.2758","journal-title":"AJR Am J Roentgenol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-03996-1","article-title":"Can whole-body MRI replace CT in management of metastatic testicular cancer? A prospective, non-inferiority study","volume":"149","author":"Larsen SK","year":"2023","unstructured":"Larsen SK, L\u00f8gager V, Bylov C, Nellemann H, Agerb\u00e6k M, Als AB, Pedersen EM. Can whole-body MRI replace CT in management of metastatic testicular cancer? A prospective, non-inferiority study. J Cancer Res Clin Oncol. 2023, 149:1221-30. 10.1007\/s00432-022-03996-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/life12020212","article-title":"Whole body MRI in the detection of lymph node metastases in patients with testicular germ cell cancer","volume":"12","author":"Pasoglou V","year":"2022","unstructured":"Pasoglou V, Van Nieuwenhove S, Van Damme J, et al.. Whole body MRI in the detection of lymph node metastases in patients with testicular germ cell cancer. Life (Basel). 2022, 12:10.3390\/life12020212","journal-title":"Life (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2020.1725243","article-title":"Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: a prospective trial","volume":"59","author":"Laukka M","year":"2020","unstructured":"Laukka M, Mannisto S, Beule A, Kouri M, Blomqvist C. Comparison between CT and MRI in detection of metastasis of the retroperitoneum in testicular germ cell tumors: a prospective trial. Acta Oncol. 2020, 59:660-5. 10.1080\/0284186X.2020.1725243","journal-title":"Acta Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326759-evaluating-the-effectiveness-of-mri-versus-ct-in-identifying-retroperitoneal-lymph-node-metastasis-in-testicular-cancer-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T18:08:36Z","timestamp":1736014116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326759-evaluating-the-effectiveness-of-mri-versus-ct-in-identifying-retroperitoneal-lymph-node-metastasis-in-testicular-cancer-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.76911","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,4]]}}}